Donor Login
Contact Us
Breakthrough T1D
About
Investment Strategy
Portfolio
Our Team
News
Donor Login
Get in Touch
News and Press
The T1D Fund Announces Lucio Iannone, Ph.D., as Managing Director to Accelerate Investments in Curative T1D Therapies
June 16, 2025 |
BOSTON, Mass.
The T1D Fund Announces Daniel McNamara as Head of Strategy & Industry Engagement to Grow the T1D Fund Brand and Drive Greater Interest in T1D Investments
May 13, 2025 |
BOSTON, Mass.
Zucara Therapeutics Announces Second and Final Closing of US$25 Million Series B Financing
May 01, 2025 |
Toronto, Canada
Mozart Therapeutics Completes Ph1a Study in Healthy Adults; Data Shows MTX-101 is Well Tolerated and Selectively Activates CD8 Treg
March 17, 2025
Egle Therapeutics Strengthens its Executive Leadership Team With the Appointment of Christophe Quéva, Ph.D., as Chief Executive Officer
January 15, 2025 |
Paris, France
